Pay in installments of $6.97 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jun 29 - Jul 4
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
How compounders plan to continue making GLP 1s MOUNJARO KWIKPEN Tirzepatide 10mg 0.6ml Solution For SC Injection 3ml 1 Prefilled Pen with Needle price in the Philippines MedsGo Pharmacy Looking to slowly get off Tirzepatide. How can I slowly start? : r glp1 Let's clear the confusion , 2.5mg Tirzepatide is not low dosing. 0.25ml compounded is not low dosing. This is called standard dosing or "initial" dosage. That is not what i am constantly talking Stopping GLP 1 Receptor Agonists Why and How to Plan an Exit Strategy for Your Patients Today's Practitioner
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.5 ★★★★★
Based on 980 reviews
Sort
Product Reviews
★★★★★ 5
Mocks dispensational viewpoints on key Thessalonian chapters.
Format: Hardcover
Very good read. You really walk away feeling like an expert in the Thessalonian Epistles after reading this book because Weima always is searching for theological answers to the questions that arise within the Epistles themselves. You really see the deep unity of Paul's purpose in writing these epistles after reading this commentary. The only problems for me where I did not agree with Weima's conclusions was on dispensational issues in 1 Thess. 4 and 2 Thess. 2. Weima rejected the idea of the rapture without dealing with it at all and then proposed the idea that its talking about a "Hellenistic reception" of a king coming into a city. I don't get it, Weima thinks we do go to the sky meet the Lord in the air and then lead him to the earth, it's so preposterous. It seems like God is in control of this event not man leading Christ to the earth. If he wants to criticize the rapture 'which yes I do believe.' Make your argument. But instead Weima just says things like "so called rapture" without refuting it with logic at all. And then in another eschatological text in 2 Thess. 2 Weima rejects any kind of a literal interpretation and says "We can't actually believe that the Anti-Christ actually goes into a rebuilt Jewish temple as some dispensationalists believe." I'm paraphrasing Weima's words. Weima flat out rejects any dispensational viewpoints on these important verses and doesn't deal with them at all like he does other viewpoints. Other than that I think this was a great read. Highly recommend the book.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 28, 2016
★★★★★ 5
Very helpful, lots of detail
Format: Hardcover
Provides a lot of detail, way more than the other commentary I used. That made me have to dig through more information. So I would usually start with my more simple commentary, and if that didn’t satisfy me, I would go to this one, Weima. It gives a lot of detail, when you want that, structure, background, detail, references. It was very helpful when I went to it.
I didn’t note finding any “problems” with what I found in this commentary, but I didn’t use it on every passage.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 8, 2024
★★★★★ 5
Magisterial
Format: Hardcover
This is a simply magisterial commentary, and almost certainly the best yet on 1-2 Thessalonians. Not only does Weima present a balanced study of the backgrounds and the text itself, but his commentary serves as a thorough catalog of the secondary literature. He is fair and even-handed with positions he disagrees with, often spending more time explaining them than other commentaries do on their own preferred stance. The result is an empowerment of the reader to make their own informed decision, without being left in the dark about where Weima himself stands. This commentary fleshed out and clarified not only my grasp of the titulary subject matter, but also epistolary form and conventions across the NT. It bears the fingerprints of long and careful study, and deserves a place on the bookshelf of scholars and serious laymen alike.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 13, 2017
★★★★★ 5
The Best
Format: Kindle
Every time I read this commentary, I get into the state of thinking that fills me with love for the complexity and intricacy of God’s word. The author finds parallels, delves into languages carefully but not exhaustively, and he also deals well with alternate viewpoints. He is so fair with other views that I often draw great benefit from them. To me, these are all hallmarks of a great commentary.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 25, 2018
★★★★★ 5
especially like what was introduced about Paul's inclusion on election-- surrounded ...
Format: Hardcover
In depth. Every page is worth study! I, so far, especially like what was introduced about Paul's inclusion on election--
surrounded by/in God's love!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 8, 2014
recommand products
The Therapeutic Potential of GLP-1 Receptor Agonists in the Management of Hidradenitis Suppurativa: A Systematic Review of Anti-Inflammatory and Metabolic Effects
24.10
GLP-1s for diabetes reduce rheumatoid arthritis, gout risk
24.08
GLP-1 drugs linked to osteoporosis and gout: New study reveals higher risks
26.05
can glp 1 cause gout New research suggests that prolonged GLP-1 use may increase the risk of certain bone and joint conditions. See link below ⬇️
22.58
Recent news is raising questions about popular GLP-1 weight-loss drugs (like Ozempic and Wegovy). New research presented at a major orthopedic conference found people taking these medications had a higher risk of
23.67